Biocept Inc. (BIOCQ)
OTCMKTS: BIOCQ · Delayed Price · USD
0.00
0.00 (0.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Biocept Market Cap
Biocept has a market cap or net worth of $262.00 as of July 2, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
262.00
Enterprise Value
4.96M
1-Year Change
-100.00%
Ranking
n/a
Category
Stock Price
n/a
Market Cap Chart
Since February 5, 2014, Biocept's market cap has decreased from $40.90M to $262.00, a decrease of -100.00%. That is a compound annual growth rate of -70.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2023 | 1.10M | -87.78% |
| Dec 30, 2022 | 9.00M | -85.25% |
| Dec 31, 2021 | 61.00M | 2.52% |
| Dec 31, 2020 | 59.50M | 801.52% |
| Dec 31, 2019 | 6.60M | 88.57% |
| Dec 31, 2018 | 3.50M | -83.33% |
| Dec 29, 2017 | 21.00M | 54.41% |
| Dec 30, 2016 | 13.60M | -47.69% |
| Dec 31, 2015 | 26.00M | 136.36% |
| Dec 31, 2014 | 11.00M | -73.11% |
| Feb 5, 2014 | 40.90M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 869.02B |
| Novo Nordisk | 643.34B |
| UnitedHealth Group | 455.27B |
| Johnson & Johnson | 352.43B |
| Merck & Co. | 323.95B |
| AbbVie | 300.85B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |